Centessa Pharmaceuticals (CNTA) News Today $16.91 -0.36 (-2.08%) As of 09:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNTA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Purchased by Nantahala Capital Management LLC3 hours ago | marketbeat.comCentessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference3 hours ago | globenewswire.comArmistice Capital LLC Takes $6.73 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTASeptember 2 at 8:33 AM | marketbeat.comWalleye Capital LLC Invests $1.18 Million in Centessa Pharmaceuticals PLC Sponsored ADR $CNTASeptember 2 at 4:36 AM | marketbeat.comWellington Management Group LLP Has $2 Million Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTASeptember 2 at 4:11 AM | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by Driehaus Capital Management LLCSeptember 1 at 5:37 AM | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Research Coverage Started at OppenheimerSeptember 1 at 2:27 AM | americanbankingnews.comCentessa Pharmaceuticals (NASDAQ:CNTA) Now Covered by OppenheimerAugust 31 at 9:28 AM | marketbeat.comSiren L.L.C. Has $42.57 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTAAugust 31 at 6:29 AM | marketbeat.comCentessa rated Outperform at Oppenheimer on ORX750 potentialAugust 29, 2025 | seekingalpha.comCentessa Pharmaceuticals PLC Sponsored ADR $CNTA is Affinity Asset Advisors LLC's 10th Largest PositionAugust 28, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTAAugust 28, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Cuts Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTAAugust 26, 2025 | marketbeat.comRussell Investments Group Ltd. Invests $3.27 Million in Centessa Pharmaceuticals PLC Sponsored ADR $CNTAAugust 26, 2025 | marketbeat.comAberdeen Group plc Takes $1.31 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTAAugust 24, 2025 | marketbeat.comPiper Sandler Remains a Buy on Centessa Pharmaceuticals (CNTA)August 19, 2025 | theglobeandmail.comFY2025 Earnings Estimate for CNTA Issued By Chardan CapitalAugust 19, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) General Counsel Iqbal J. Hussain Sells 6,000 SharesAugust 17, 2025 | marketbeat.comLeerink Partnrs Has Negative Outlook of CNTA FY2025 EarningsAugust 17, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Lowered to "Sell" Rating by Wall Street ZenAugust 17, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Receives Buy Rating from Chardan CapitalAugust 14, 2025 | marketbeat.comRegents of The University of California Buys Shares of 81,884 Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)August 14, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Announces Earnings Results, Misses Expectations By $0.04 EPSAugust 13, 2025 | marketbeat.comCentessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025August 12, 2025 | finanznachrichten.deCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025August 12, 2025 | globenewswire.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Recommendation of "Buy" by BrokeragesAugust 11, 2025 | marketbeat.comCentessa Pharmaceuticals (CNTA) Expected to Announce Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comXTX Topco Ltd Purchases 18,377 Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)August 6, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 3.8% - Here's What HappenedAugust 5, 2025 | marketbeat.comTD Asset Management Inc Sells 53,592 Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)August 2, 2025 | marketbeat.comTruist Initiates Buy on Centessa Pharmaceuticals (CNTA) with $30 PT, Cites Orexin Drug PotentialAugust 1, 2025 | msn.comMario Alberto Accardi Sells 8,322 Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) StockJuly 31, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 9.2% - Still a Buy?July 31, 2025 | marketbeat.comInsider Selling: Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells 8,322 Shares of StockJuly 31, 2025 | insidertrades.comWindmill Hill Asset Management Ltd Takes Position in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)July 27, 2025 | marketbeat.comInsider Selling: Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells 10,000 Shares of StockJuly 26, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells $155,600.00 in StockJuly 26, 2025 | insidertrades.comCerity Partners LLC Invests $471,000 in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)July 26, 2025 | marketbeat.comTruist Securities Initiates Coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (CNTA) with Buy RecommendationJuly 23, 2025 | msn.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) CEO Sells $875,600.00 in StockJuly 22, 2025 | insidertrades.comSaurabh Saha Sells 55,000 Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) StockJuly 21, 2025 | marketbeat.comTruist Financial Begins Coverage on Centessa Pharmaceuticals (NASDAQ:CNTA)July 21, 2025 | marketbeat.comWildcat Capital Management LLC Invests $4.05 Million in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)July 17, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Buy" by AnalystsJuly 16, 2025 | marketbeat.comCentessa Pharmaceuticals Advances Neurological Drug ORX142 to Clinical TrialsJuly 15, 2025 | msn.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 7.9% - Still a Buy?July 9, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Shares Bought by HighMark Wealth Management LLCJune 27, 2025 | marketbeat.comCNTA Centessa Pharmaceuticals plc - Seeking AlphaJune 27, 2025 | seekingalpha.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 3.8% on Insider SellingJune 26, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells $138,600.00 in StockJune 25, 2025 | marketbeat.com Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNTA Media Mentions By Week CNTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTA News Sentiment▼1.300.96▲Average Medical News Sentiment CNTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTA Articles This Week▼145▲CNTA Articles Average Week Get the Latest News and Ratings for CNTA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ROIV News RVMD News GRFS News RYTM News LEGN News ABVX News AXSM News RNA News NUVL News MRUS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTA) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
